Mondrian Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Takeda Pharmaceutical
TAK
|
+$48.5M |
| 2 |
Colgate-Palmolive
CL
|
+$29.2M |
| 3 |
Johnson & Johnson
JNJ
|
+$20.2M |
| 4 |
SRCL
Stericycle Inc
SRCL
|
+$18.6M |
| 5 |
Synchrony
SYF
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$86.3M |
| 2 |
Itaú Unibanco
ITUB
|
+$56.1M |
| 3 |
Omnicom Group
OMC
|
+$55.1M |
| 4 |
CAE Inc. Common Shares
CAE
|
+$40.4M |
| 5 |
TSMC
TSM
|
+$39.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.88% |
| 2 | Industrials | 22.47% |
| 3 | Technology | 15.78% |
| 4 | Healthcare | 15% |
| 5 | Energy | 6.79% |
Similar funds
Mondrian Investment Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Mondrian Investment Partners held 136 positions worth $2.72B, down 15% from $3.19B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Mondrian Investment Partners withdrew a net $254M in Q4 2018, closing 8 positions and reducing 32 holdings. Its most notable exit was Omnicom Group, an estimated $55.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.
Against the trend, Mondrian Investment Partners opened a new position in Takeda Pharmaceutical worth $48.9M.
- Mondrian Investment Partners's largest Q4 2018 buy was Takeda Pharmaceutical: 2,873,870 shares worth $48.9M.
- Mondrian Investment Partners added most to Colgate-Palmolive in Q4 2018, an estimated $29.2M increase.
- Mondrian Investment Partners's biggest Q4 2018 reduction was Embraer S.A. ADS, cutting an estimated $86.3M.
- Mondrian Investment Partners fully exited Omnicom Group in Q4 2018, selling an estimated $55.1M.
- Mondrian Investment Partners's ten largest holdings make up 46% of its $2.72B portfolio in Q4 2018.
- Mondrian Investment Partners opened 14 new positions and closed 8 in Q4 2018.
- Mondrian Investment Partners's portfolio value fell 15% quarter-over-quarter to $2.72B.
Based on Mondrian Investment Partners's 13F filing for Q4 2018, filed 24 Jan 2019.